Relay Therapeutics (RLAY) Research & Development (2020 - 2025)
Historic Research & Development for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to $68.3 million.
- Relay Therapeutics' Research & Development fell 1090.72% to $68.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $274.0 million, marking a year-over-year decrease of 1658.0%. This contributed to the annual value of $319.1 million for FY2024, which is 331.16% down from last year.
- Latest data reveals that Relay Therapeutics reported Research & Development of $68.3 million as of Q3 2025, which was down 1090.72% from $63.9 million recorded in Q2 2025.
- Relay Therapeutics' 5-year Research & Development high stood at $92.0 million for Q2 2024, and its period low was $30.6 million during Q1 2021.
- Its 5-year average for Research & Development is $67.1 million, with a median of $68.1 million in 2024.
- Per our database at Business Quant, Relay Therapeutics' Research & Development skyrocketed by 10837.72% in 2021 and then plummeted by 3054.07% in 2025.
- Over the past 5 years, Relay Therapeutics' Research & Development (Quarter) stood at $51.9 million in 2021, then increased by 29.61% to $67.3 million in 2022, then grew by 15.19% to $77.5 million in 2023, then decreased by 12.16% to $68.1 million in 2024, then grew by 0.27% to $68.3 million in 2025.
- Its Research & Development was $68.3 million in Q3 2025, compared to $63.9 million in Q2 2025 and $73.8 million in Q1 2025.